Clinical Trial

Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

Study acronym: MCTAHS
Recruiting
View on ClinicalTrials.gov →
Summary
Acute hemorrhagic stroke is a series of neurosurgical diseases characterized by bleeding with high morbidity and mortality. It accounts for about 20% of all strokes worldwide and mainly includes subtypes such as intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Multimodal computed tomography including non-contrast computed tomography, computed tomography angiography and computed tomography perfusion, is of great important in understanding pathophysiological changes, evaluating prognosis and guiding interventions in these diseases.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-09-24; most recent amendment 2025-04-02.
Trial Details
NCT Number NCT06061185
Lead Sponsor Xiaolin Chen, MD
Collaborators: Peking University International Hospital, Zhangzhou Municipal Hospital of Fujian Province, The First Affiliated Hospital of Shanxi Medical University, Santai County People's Hospital, Jiujiang No.1 People's Hospital, Qin Zhou NO.1 People's Hospital, Sichuan Academy of Medical Sciences, Linyi People's Hospital
Conditions Acute Hemorrhagic Stroke
Enrollment 10,000 participants
Start Date 2020-01-01
Primary Completion 2032-03-01 (estimated)
Study Completion 2032-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-04